Terminal · Institutions
Every 13F-reported equity position this quarter, with its quarter-over-quarter change — each row traces back to the SEC filing.
Every 13F-reported equity position this quarter, with its quarter-over-quarter change — each row traces back to the SEC filing.
DIADEMA PARTNERS LP (CIK 2026172) reported $587.7M across 60 reported positions in its SEC 13F filing for 2026-03-31. Largest positions: UTHR ($51.9M, 8.83%), VRTX ($43.3M, 7.37%), VKTX ($38.5M, 6.56%), CAPR ($31.4M, 5.34%), ABVX ($30.5M, 5.19%). Source: SEC Form 13F.
| Rank | Ticker | Company | Value | % Portfolio | Shares | Action |
|---|---|---|---|---|---|---|
| 1 | UTHR | UNITED THERAPEUTICS CORP DEL | $51.9M | 8.83% | 87,503 | Added |
| 2 | VRTX | VERTEX PHARMACEUTICALS INC | $43.3M | 7.37% | 96,940 | Trimmed |
| 3 | VKTX | VIKING THERAPEUTICS INC | $38.5M | 6.56% | 1.2M | Trimmed |
| 4 | CAPR | CAPRICOR THERAPEUTICS INC | $31.4M | 5.34% | 1.0M | Added |
| 5 | ABVX | ABIVAX SA | $30.5M | 5.19% | 275,944 | Added |
| 6 | LQDA | LIQUIDIA CORPORATION | $26.9M | 4.57% | 712,100 | Added |
| 7 | RVMD | REVOLUTION MEDICINES INC | $20.1M | 3.41% | 206,372 | Added |
| 8 | APGE | APOGEE THERAPEUTICS INC | $18.7M | 3.19% | 222,500 | Added |
| 9 | BBIO | BRIDGEBIO PHARMA INC | $18.6M | 3.16% | 250,000 | New |
| 10 | INCY | INCYTE CORP | $17.3M | 2.94% | 183,429 | Added |
| 11 | KOD | KODIAK SCIENCES INC | $16.8M | 2.85% | 440,062 | Added |
| 12 | CYTK | CYTOKINETICS INC | $16.5M | 2.80% | 250,000 | New |
| 13 | JNJ | JOHNSON & JOHNSON | $13.1M | 2.24% | 53,771 | Trimmed |
| 14 | COGT | COGENT BIOSCIENCES INC | $12.4M | 2.11% | 322,764 | Added |
| 15 | MRK | MERCK & CO INC | $12.0M | 2.05% | 100,000 | New |
| 16 | JAZZ | JAZZ PHARMACEUTICALS PLC | $10.4M | 1.76% | 54,755 | Trimmed |
| 17 | GPCR | STRUCTURE THERAPEUTICS INC | $9.6M | 1.64% | 199,734 | Added |
| 18 | TERN | TERNS PHARMACEUTICALS INC | $9.6M | 1.63% | 181,752 | Trimmed |
| 19 | QURE | UNIQURE NV | $9.5M | 1.61% | 580,200 | Added |
| 20 | ROIV | ROIVANT SCIENCES LTD | $9.3M | 1.58% | 335,800 | Added |
| 21 | BMRN | BIOMARIN PHARMACEUTICAL INC | $8.4M | 1.42% | 148,229 | Added |
| 22 | MRNA | MODERNA INC | $8.1M | 1.38% | 159,400 | New |
| 23 | TGTX | TG THERAPEUTICS INC | $6.9M | 1.17% | 206,928 | Trimmed |
| 24 | CORT | CORCEPT THERAPEUTICS INC | $6.8M | 1.16% | 168,500 | Trimmed |
| 25 | EWTX | EDGEWISE THERAPEUTICS INC | $6.7M | 1.14% | 212,500 | Added |
Source: SEC Form 13F filings · as of 2026-03-31